Sofosbuvir Plus Ribavirin for HCV Genotype 2 Infection Sofosbuvir Plus Ribavirin for HCV Genotype 2 Infection

This large, international cohort study confirms the effectiveness and safety of the all-oral combination of sofosbuvir and ribavirin for treatment of HCV genotype 2.Gut
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news